BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Padia SA, Lewandowski RJ, Johnson GE, Sze DY, Ward TJ, Gaba RC, Baerlocher MO, Gates VL, Riaz A, Brown DB, Siddiqi NH, Walker TG, Silberzweig JE, Mitchell JW, Nikolic B, Salem R. Radioembolization of Hepatic Malignancies: Background, Quality Improvement Guidelines, and Future Directions. Journal of Vascular and Interventional Radiology 2017;28:1-15. [DOI: 10.1016/j.jvir.2016.09.024] [Cited by in Crossref: 54] [Cited by in F6Publishing: 45] [Article Influence: 10.8] [Reference Citation Analysis]
Number Citing Articles
1 Core JM, Frey GT, Sharma A, Bussone ST, Legout JD, McKinney JM, Lewis AR, Ritchie C, Devcic Z, Paz-Fumagalli R, Toskich BB. Increasing Yttrium-90 Dose Conformality Using Proximal Radioembolization Enabled by Distal Angiosomal Truncation for the Treatment of Hepatic Malignancy. J Vasc Interv Radiol 2020;31:934-42. [PMID: 32381352 DOI: 10.1016/j.jvir.2019.12.017] [Reference Citation Analysis]
2 Cardarelli-Leite L, Chung J, Klass D, Marquez V, Chou F, Ho S, Walton H, Lim H, Tae Wan Kim P, Hadjivassiliou A, Liu DM. Ablative Transarterial Radioembolization Improves Survival in Patients with HCC and Portal Vein Tumor Thrombus. Cardiovasc Intervent Radiol 2020;43:411-22. [PMID: 31909439 DOI: 10.1007/s00270-019-02404-5] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 5.0] [Reference Citation Analysis]
3 Núñez KG, Sandow T, Fort D, Patel J, Hibino M, Carmody I, Cohen AJ, Thevenot P. Baseline Alpha-Fetoprotein, Alpha-Fetoprotein-L3, and Des-Gamma-Carboxy Prothrombin Biomarker Status in Bridge to Liver Transplant Outcomes for Hepatocellular Carcinoma. Cancers (Basel) 2021;13:4765. [PMID: 34638251 DOI: 10.3390/cancers13194765] [Reference Citation Analysis]
4 Shah RM, Sheikh S, Shah J, Vivian E, Mejia A, Shahin I, Mantry PS. Prognostic factors of unresectable hepatocellular carcinoma treated with yttrium-90 radioembolization: results from a large cohort over 13 years at a single center. J Gastrointest Oncol 2021;12:1718-31. [PMID: 34532122 DOI: 10.21037/jgo-20-435] [Reference Citation Analysis]
5 Cappelli A, Sangro P, Mosconi C, Deppe I, Terzi E, Bilbao JI, Rodriguez-Fraile M, De Benedittis C, Ricke J, Golfieri R, Sangro B. Transarterial radioembolization in patients with hepatocellular carcinoma of intermediate B2 substage. Eur J Nucl Med Mol Imaging 2019;46:661-8. [PMID: 30209522 DOI: 10.1007/s00259-018-4152-7] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
6 Triviño-Ibáñez EM, Pardo Moreno P, Ciampi Dopazo JJ, Ramos-Font C, Ruiz Villaverde G, González-Flores E, Navarro Vergara PF, Rashki M, Gómez-Río M, Rodríguez-Fernández A. Biomarkers associated with survival and favourable outcome of radioembolization with yttrium-90 glass microspheres for colon cancer liver metastases: Single centre experience. Rev Esp Med Nucl Imagen Mol 2021:S2253-654X(21)00129-3. [PMID: 34294586 DOI: 10.1016/j.remn.2021.05.004] [Reference Citation Analysis]
7 Padia SA, Johnson GE, Agopian VG, DiNorcia J, Srinivasa RN, Sayre J, Shin DS. Yttrium-90 radiation segmentectomy for hepatic metastases: A multi-institutional study of safety and efficacy. J Surg Oncol 2021;123:172-8. [PMID: 32944980 DOI: 10.1002/jso.26223] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
8 Qadan M, Kothary N, Sangro B, Palta M. The Treatment of Hepatocellular Carcinoma With Portal Vein Tumor Thrombosis. Am Soc Clin Oncol Educ Book 2020;40:1-8. [PMID: 32213090 DOI: 10.1200/EDBK_280811] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
9 Jonczyk M, Collettini F, Schnapauff D, Geisel D, Böning G, Lüdemann WM, Wieners G, Hamm B, Gebauer B. Visibility of Hypovascularized Liver Tumors during Intra-Arterial Therapy Using Split-Bolus Single-Phase Cone Beam CT. Cardiovasc Intervent Radiol 2019;42:260-7. [PMID: 30374613 DOI: 10.1007/s00270-018-2101-2] [Reference Citation Analysis]
10 Johnson GE, Padia SA. Yttrium-90 Radiation Segmentectomy. Semin Intervent Radiol 2020;37:537-42. [PMID: 33328710 DOI: 10.1055/s-0040-1720953] [Reference Citation Analysis]
11 Walrand S, Hesse M, d'Abadie P, Jamar F. Hepatic Arterial Buffer Response in Liver Radioembolization and Potential Use for Improved Cancer Therapy. Cancers (Basel) 2021;13:1537. [PMID: 33810511 DOI: 10.3390/cancers13071537] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
12 Schiro BJ, Amour ES, Harnain C, Gandhi RT. Management of High Hepatopulmonary Shunts in the Setting of Y90 Radioembolization. Tech Vasc Interv Radiol 2019;22:58-62. [PMID: 31079711 DOI: 10.1053/j.tvir.2019.02.004] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
13 d'Abadie P, Walrand S, Goffette P, Amini N, Maanen AV, Lhommel R, Jamar F. Antireflux catheter improves tumor targeting in liver radioembolization with resin microspheres. Diagn Interv Radiol 2021;27:768-73. [PMID: 34792032 DOI: 10.5152/dir.2021.20785] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
14 Kennedy A, Brown DB, Feilchenfeldt J, Marshall J, Wasan H, Fakih M, Gibbs P, Knuth A, Sangro B, Soulen MC, Pittari G, Sharma RA. Safety of selective internal radiation therapy (SIRT) with yttrium-90 microspheres combined with systemic anticancer agents: expert consensus. J Gastrointest Oncol 2017;8:1079-99. [PMID: 29299370 DOI: 10.21037/jgo.2017.09.10] [Cited by in Crossref: 16] [Cited by in F6Publishing: 12] [Article Influence: 3.2] [Reference Citation Analysis]
15 Triviño-Ibáñez EM, Pardo Moreno P, Ciampi Dopazo JJ, Ramos-Font C, Ruiz Villaverde G, González-Flores E, Navarro Vergara PF, Rashki M, Gómez-Río M, Rodríguez-Fernández A. Biomarkers associated with survival and favourable outcome of radioembolization with yttrium-90 glass microspheres for colon cancer liver metastases: Single centre experience. Rev Esp Med Nucl Imagen Mol (Engl Ed) 2021:S2253-8089(21)00128-2. [PMID: 34454892 DOI: 10.1016/j.remnie.2021.08.001] [Reference Citation Analysis]
16 Ridouani F, Ghosn M, Doustaly R, Gonzalez-Aguirre AJ, Ziv E, Solomon SB, Edward Boas F, Yarmohammadi H. Accuracy of a CBCT-based virtual injection software for vessel detection during hepatic arterial embolization. Eur J Radiol 2022;150:110273. [PMID: 35338952 DOI: 10.1016/j.ejrad.2022.110273] [Reference Citation Analysis]
17 Kim HC, Kim YJ, Lee JH, Suh KS, Chung JW. Feasibility of Boosted Radioembolization for Hepatocellular Carcinoma Larger than 5 cm. J Vasc Interv Radiol 2019;30:1-8. [PMID: 30293734 DOI: 10.1016/j.jvir.2018.07.002] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
18 Marsala A, Lee EW, Padia SA. Yttrium-90 Radioembolization for Metastatic Colorectal Cancer: Outcomes by Number of Lines of Therapy. Semin Intervent Radiol 2017;34:116-20. [PMID: 28579679 DOI: 10.1055/s-0037-1602711] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.6] [Reference Citation Analysis]
19 Kemeny N, Kurilova I, Li J, Camacho JC, Sofocleous CT. Liver-Directed and Systemic Therapies for Colorectal Cancer Liver Metastases. Cardiovasc Intervent Radiol 2019;42:1240-54. [DOI: 10.1007/s00270-019-02284-9] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
20 Biederman DM, Titano JJ, Korff RA, Fischman AM, Patel RS, Nowakowski FS, Lookstein RA, Kim E. Radiation Segmentectomy versus Selective Chemoembolization in the Treatment of Early-Stage Hepatocellular Carcinoma. Journal of Vascular and Interventional Radiology 2018;29:30-37.e2. [DOI: 10.1016/j.jvir.2017.08.026] [Cited by in Crossref: 28] [Cited by in F6Publishing: 20] [Article Influence: 7.0] [Reference Citation Analysis]
21 Kobe A, Zgraggen J, Messmer F, Puippe G, Sartoretti T, Alkadhi H, Pfammatter T, Mannil M. Prediction of treatment response to transarterial radioembolization of liver metastases: Radiomics analysis of pre-treatment cone-beam CT: A proof of concept study. Eur J Radiol Open 2021;8:100375. [PMID: 34485629 DOI: 10.1016/j.ejro.2021.100375] [Reference Citation Analysis]
22 Huang YH, Park BV, Chen YF, Gaba RC, Guzman G, Lokken RP. Locoregional Therapy of Hepatocellular-Cholangiocarcinoma versus Hepatocellular Carcinoma: A Propensity Score-Matched Study. J Vasc Interv Radiol 2019;30:1317-24. [PMID: 31375450 DOI: 10.1016/j.jvir.2019.03.024] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
23 Khattab M, Howard B, Al-rifai S, Torgerson T, Vassar M. Adherence to the RIGHT statement in Society of Interventional Radiology guidelines. Journal of Osteopathic Medicine 2021;121:11-24. [DOI: 10.1515/jom-2020-0024] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
24 d'Abadie P, Walrand S, Hesse M, Annet L, Borbath I, Van den Eynde M, Lhommel R, Jamar F. Prediction of tumor response and patient outcome after radioembolization of hepatocellular carcinoma using 90Y-PET-computed tomography dosimetry. Nucl Med Commun 2021;42:747-54. [PMID: 33741864 DOI: 10.1097/MNM.0000000000001395] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
25 Jafargholi Rangraz E, Coudyzer W, Maleux G, Baete K, Deroose CM, Nuyts J. Multi-modal image analysis for semi-automatic segmentation of the total liver and liver arterial perfusion territories for radioembolization. EJNMMI Res 2019;9:19. [PMID: 30788640 DOI: 10.1186/s13550-019-0485-x] [Cited by in Crossref: 11] [Cited by in F6Publishing: 7] [Article Influence: 3.7] [Reference Citation Analysis]
26 Zubiri L, Bilbao JI, Rodríguez J, Sangro B. Selective internal radiation therapy: an effective treatment for hormonal syndromes in pancreatic neuroendocrine tumors. Hepat Oncol 2018;5:HEP09. [PMID: 31293777 DOI: 10.2217/hep-2017-0025] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
27 Joo I, Kim HC, Kim GM, Paeng JC. Imaging Evaluation Following 90Y Radioembolization of Liver Tumors: What Radiologists Should Know. Korean J Radiol 2018;19:209-22. [PMID: 29520178 DOI: 10.3348/kjr.2018.19.2.209] [Cited by in Crossref: 17] [Cited by in F6Publishing: 12] [Article Influence: 4.3] [Reference Citation Analysis]
28 Abdallah MA, Wongjarupong N, Hassan MA, Taha W, Abdalla A, Bampoh S, Onyirioha K, Nelson M, Glubranson LA, Wiseman GA, Fleming CJ, Andrews JC, Mahipal A, Roberts LR. The efficacy, safety, and predictors of outcomes of transarterial radioembolization for hepatocellular carcinoma: a retrospective study. Expert Rev Gastroenterol Hepatol 2020;14:619-29. [PMID: 32490691 DOI: 10.1080/17474124.2020.1777856] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
29 Padia SA, Johnson GE, Lewandowski RJ, Gabr A, Toskich BB. Transarterial Yttrium-90 Radioembolization of Hepatocellular Carcinoma Perfused by the Cystic Artery: Multi-institutional Feasibility Study. J Vasc Interv Radiol 2020;31:2022-7. [PMID: 33187861 DOI: 10.1016/j.jvir.2020.08.014] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
30 d'Abadie P, Walrand S, Hesse M, Amini N, Lhommel R, Sawadogo K, Jamar F. Accurate non-tumoral 99mTc-MAA absorbed dose prediction to plan optimized activities in liver radioembolization using resin microspheres. Phys Med 2021;89:250-7. [PMID: 34438353 DOI: 10.1016/j.ejmp.2021.07.032] [Reference Citation Analysis]
31 d’Abadie P, Walrand S, Lhommel R, Hesse M, Borbath I, Jamar F. Optimization of the Clinical Effectiveness of Radioembolization in Hepatocellular Carcinoma with Dosimetry and Patient-Selection Criteria. Current Oncology 2022;29:2422-34. [DOI: 10.3390/curroncol29040196] [Reference Citation Analysis]
32 Kim HC, Lee M, Lee JH, Paeng JC, Kim YJ, Chung JW. Combination of 1st and 2nd Week Dosing of Glass Yttrium-90 Microspheres for Superselective Radioembolization. In Vivo 2020;34:2763-8. [PMID: 32871812 DOI: 10.21873/invivo.12100] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
33 Goh WXT, Leong S, Too CW, Cheng LT, Saffari SE, Lee RZ, Ng STS, Lo RHG, Tay KH, Chan SXJM, Gogna A, Irani FG, Venkatanarasimha N, Loke KSH, Chow PKH, Ng DCE, Urlings TAJ, Patel A, Damodharan K, Toh LHW, Tan BS. Catheter-Directed Computed Tomography Hepatic Angiography for Yttrium-90 Selective Internal Radiotherapy of Hepatocellular Carcinoma Reduces Prophylactic Embolization of Extrahepatic Vessels. Cardiovasc Intervent Radiol 2020;43:478-87. [PMID: 31705243 DOI: 10.1007/s00270-019-02362-y] [Cited by in Crossref: 2] [Article Influence: 0.7] [Reference Citation Analysis]
34 Floridi C, Pesapane F, Angileri SA, De Palma D, Fontana F, Caspani F, Barile A, Del Sole A, Masciocchi C, Lucignani G, Carrafiello G. Yttrium-90 radioembolization treatment for unresectable hepatocellular carcinoma: a single-centre prognostic factors analysis. Med Oncol 2017;34. [DOI: 10.1007/s12032-017-1021-3] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 2.4] [Reference Citation Analysis]
35 Hardaway JC, Prince E, Arepally A, Katz SC. Regional Infusion of Chimeric Antigen Receptor T Cells to Overcome Barriers for Solid Tumor Immunotherapy. J Vasc Interv Radiol 2018;29:1017-1021.e1. [PMID: 29935783 DOI: 10.1016/j.jvir.2018.03.001] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 2.3] [Reference Citation Analysis]
36 Hong K, Akinwande O, Bodei L, Chamarthy MR, Devlin PM, Elman S, Ganguli S, Kennedy AS, Koo SJ, Ouhib Z, Padia SA, Salem R, Selwyn RG, Yashar CM, Yoo DC, Zaki BI, Hartford AC, Trimmer CK. ACR-ABS-ACNM-ASTRO-SIR-SNMMI practice parameter for selective internal radiation therapy or radioembolization for treatment of liver malignancies. Brachytherapy 2021;20:497-511. [PMID: 33824051 DOI: 10.1016/j.brachy.2021.01.006] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
37 Goh WXT, Too CW, Lee KA, Tan BS, Tay KH, Chandramohan S, Lo RHG, Irani FG, Venkatanarasimha N, Damodharan K, Kumar KKP, Zhuang KD, Chua JME, Bangaragiri A, Leong S. Management of arterial dissections in 12 patients during transarterial chemoembolization and yttrium-90 selective internal radiotherapy for primary and secondary liver tumours. Abdom Radiol (NY) 2021;46:1737-45. [PMID: 33052468 DOI: 10.1007/s00261-020-02810-1] [Reference Citation Analysis]
38 Lucatelli P, De Rubeis G, Trobiani C, Ungania S, Rocco B, De Gyurgyokai SZ, Masi M, Pecorella I, Cappelli F, Lai Q, Catalano C, Vallati G. In Vivo Comparison of Micro-Balloon Interventions (MBI) Advantage: A Retrospective Cohort Study of DEB-TACE Versus b-TACE and of SIRT Versus b-SIRT. Cardiovasc Intervent Radiol 2022. [PMID: 35037086 DOI: 10.1007/s00270-021-03035-5] [Reference Citation Analysis]
39 Kessler J, Park JJ. Yttrium-90 Radioembolization After Local Hepatic Therapy: How Prior Treatments Impact Patient Selection, Dosing, and Toxicity. Tech Vasc Interv Radiol 2019;22:112-6. [PMID: 31079707 DOI: 10.1053/j.tvir.2019.02.012] [Cited by in Crossref: 2] [Article Influence: 0.7] [Reference Citation Analysis]
40 Lopez R, Thompson S, Fleming C, Price K, Andrews J. Yttrium-90 Radioembolization for Treatment of Hepatic Metastasis from Salivary Gland Adenoid Cystic Carcinoma in 4 Patients. J Vasc Interv Radiol 2021;32:628-30. [PMID: 33390298 DOI: 10.1016/j.jvir.2020.12.006] [Reference Citation Analysis]
41 Kim AY, Frantz S, Brower J, Akhter N. Radioembolization with Yttrium-90 Microspheres for the Treatment of Liver Metastases of Pancreatic Adenocarcinoma: A Multicenter Analysis. Journal of Vascular and Interventional Radiology 2019;30:298-304.e2. [DOI: 10.1016/j.jvir.2018.09.020] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 4.0] [Reference Citation Analysis]
42 Kim Y, Lee HA, Lee JS, Jeon MY, Kim BK, Park JY, Kim DY, Ahn SH, Um SH, Seo YS, Kim SU. Association Between Curative Treatment after Transarterial Radioembolization and Better Survival Outcomes in Patients with Hepatocellular Carcinoma. Cancer Invest 2021;39:274-83. [PMID: 33356630 DOI: 10.1080/07357907.2020.1870126] [Reference Citation Analysis]
43 Jafargholi Rangraz E, Tang X, Van Laeken C, Maleux G, Dekervel J, Van Cutsem E, Verslype C, Baete K, Nuyts J, Deroose CM. Quantitative comparison of pre-treatment predictive and post-treatment measured dosimetry for selective internal radiation therapy using cone-beam CT for tumor and liver perfusion territory definition. EJNMMI Res 2020;10:94. [PMID: 32797332 DOI: 10.1186/s13550-020-00675-5] [Reference Citation Analysis]
44 Mulcahy MF, Mahvash A, Pracht M, Montazeri AH, Bandula S, Martin RCG 2nd, Herrmann K, Brown E, Zuckerman D, Wilson G, Kim TY, Weaver A, Ross P, Harris WP, Graham J, Mills J, Yubero Esteban A, Johnson MS, Sofocleous CT, Padia SA, Lewandowski RJ, Garin E, Sinclair P, Salem R; EPOCH Investigators. Radioembolization With Chemotherapy for Colorectal Liver Metastases: A Randomized, Open-Label, International, Multicenter, Phase III Trial. J Clin Oncol 2021;39:3897-907. [PMID: 34541864 DOI: 10.1200/JCO.21.01839] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
45 Wehrenberg-klee E, Gandhi RT, Ganguli S. Patient Selection and Clinical Outcomes of Y90 in Hepatocellular Carcinoma. Techniques in Vascular and Interventional Radiology 2019;22:70-3. [DOI: 10.1053/j.tvir.2019.02.006] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
46 Nam JY, Lee YB, Lee JH, Yu SJ, Kim HC, Chung JW, Yoon JH, Kim YJ. A Prognostic Prediction Model of Transarterial Radioembolization in Hepatocellular Carcinoma: SNAP-HCC. Dig Dis Sci 2021. [PMID: 33538921 DOI: 10.1007/s10620-021-06843-4] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
47 Nahon P, Aubé C, Moga L, Chalaye J, Guiu B, Luciani A, Rode A, Ronot M, Seror O, Soussan M, Sutter O, Bourlière M, Bureau C, de Lédinghen V, Ganne-Carrié N. NON-INVASIVE DIAGNOSIS AND FOLLOW-UP OF PRIMARY MALIGNANT LIVER TUMOURS. Clin Res Hepatol Gastroenterol 2021;:101766. [PMID: 34332137 DOI: 10.1016/j.clinre.2021.101766] [Reference Citation Analysis]
48 Li MD, Chu KF, DePietro A, Wu V, Wehrenberg-Klee E, Zurkiya O, Liu RW, Ganguli S. Same-Day Yttrium-90 Radioembolization: Feasibility with Resin Microspheres. J Vasc Interv Radiol. 2019;30:314-319. [PMID: 30819470 DOI: 10.1016/j.jvir.2018.10.016] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.7] [Reference Citation Analysis]
49 Madoff DC, Odisio BC, Schadde E, Gaba RC, Bennink RJ, van Gulik TM, Guiu B. Improving the Safety of Major Resection for Hepatobiliary Malignancy: Portal Vein Embolization and Recent Innovations in Liver Regeneration Strategies. Curr Oncol Rep 2020;22:59. [PMID: 32415401 DOI: 10.1007/s11912-020-00922-x] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 4.5] [Reference Citation Analysis]
50 Wu V, Li MD, Goodwin JS, Wehrenberg-Klee EP, Zurkiya O, Kalva SP, Ganguli S. Yttrium-90 Hepatic Radioembolization for Advanced Chemorefractory Metastatic Colorectal Cancer: Survival Outcomes Based on Right- Versus Left-Sided Primary Tumor Location. AJR Am J Roentgenol 2021;217:1141-52. [PMID: 33594907 DOI: 10.2214/AJR.20.25315] [Reference Citation Analysis]
51 Vardar BU, Meram E, Karaoglu K, Liang M, Yu M, Laeseke P, Ozkan OS. Radioembolization Followed by Transarterial Chemoembolization in Hepatocellular Carcinoma. Cureus. [DOI: 10.7759/cureus.23783] [Reference Citation Analysis]
52 Makary MS, Ramsell S, Miller E, Beal EW, Dowell JD. Hepatocellular carcinoma locoregional therapies: Outcomes and future horizons. World J Gastroenterol 2021; 27(43): 7462-7479 [PMID: 34887643 DOI: 10.3748/wjg.v27.i43.7462] [Reference Citation Analysis]
53 Brown D, Krebs H, Brower J, O'Hara R, Wang E, Vaheesan K, Du L, Matsuoka L, D'Souza D, Sze DY, Golzarian J, Gandhi R, Kennedy A. Incidence and risk factors for sustained hepatic function toxicity 6 months after radioembolization: analysis of the radiation-emitting sir-spheres in non-resectable liver tumor (RESIN) registry. J Gastrointest Oncol 2021;12:639-57. [PMID: 34012656 DOI: 10.21037/jgo-20-346] [Reference Citation Analysis]
54 Laidlaw GL, Johnson GE. Recognizing and Managing Adverse Events in Y-90 Radioembolization. Semin Intervent Radiol 2021;38:453-9. [PMID: 34629713 DOI: 10.1055/s-0041-1735617] [Reference Citation Analysis]
55 Commander CW, Mauro DM. Current Approach to Planning Angiography and MAA Administration. Semin Intervent Radiol 2021;38:397-404. [PMID: 34629705 DOI: 10.1055/s-0041-1735616] [Reference Citation Analysis]
56 Tiwari T, Malone C, Foltz G, Akinwande O, Ramaswamy RS. Yttrium-90 Radioembolization: Current Clinical Practice and Review of the Recent Literature. Journal of Radiology Nursing 2019;38:86-91. [DOI: 10.1016/j.jradnu.2019.03.004] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
57 Meiers C, Taylor A, Geller B, Toskich B. Safety and initial efficacy of radiation segmentectomy for the treatment of hepatic metastases​. J Gastrointest Oncol 2018;9:311-5. [PMID: 29755770 DOI: 10.21037/jgo.2017.11.02] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 2.8] [Reference Citation Analysis]
58 Sharma NK, Kappadath SC, Chuong M, Folkert M, Gibbs P, Jabbour SK, Jeyarajah DR, Kennedy A, Liu D, Meyer JE, Mikell J, Patel RS, Yang G, Mourtada F. The American Brachytherapy Society consensus statement for permanent implant brachytherapy using Yttrium-90 microsphere radioembolization for liver tumors. Brachytherapy 2022. [DOI: 10.1016/j.brachy.2022.04.004] [Reference Citation Analysis]
59 Kouri BE. Interventional Oncology: Optimizing Transarterial Therapies for the Treatment of Hepatic Malignancy. Techniques in Vascular and Interventional Radiology 2018;21:205-22. [DOI: 10.1053/j.tvir.2018.07.002] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
60 Reimer RP, Reimer P, Mahnken AH. Assessment of Therapy Response to Transarterial Radioembolization for Liver Metastases by Means of Post-treatment MRI-Based Texture Analysis. Cardiovasc Intervent Radiol 2018;41:1545-56. [PMID: 29881933 DOI: 10.1007/s00270-018-2004-2] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 3.5] [Reference Citation Analysis]
61 Tang X, Jafargholi Rangraz E, Heeren R, Coudyzer W, Maleux G, Baete K, Verslype C, Gooding MJ, Deroose CM, Nuyts J. Segmentation-guided multi-modal registration of liver images for dose estimation in SIRT. EJNMMI Phys 2022;9. [DOI: 10.1186/s40658-022-00432-8] [Reference Citation Analysis]
62 d'Abadie P, Hesse M, Louppe A, Lhommel R, Walrand S, Jamar F. Microspheres Used in Liver Radioembolization: From Conception to Clinical Effects. Molecules 2021;26:3966. [PMID: 34209590 DOI: 10.3390/molecules26133966] [Reference Citation Analysis]
63 Chin R, Bommireddy A, Fraum TJ, Ludwig DR, Huang Y, Zoberi JE, Garcia-ramirez JL, Maughan NM, Chapman W, Korenblat K, Henke LE, Kim H, Badiyan SN. Clinical Outcomes of Patients With Unresectable Primary Liver Cancer Treated With Yttrium-90 Radioembolization With an Escalated Dose. Advances in Radiation Oncology 2022;7:100948. [DOI: 10.1016/j.adro.2022.100948] [Reference Citation Analysis]